Sign in
4

Changes in Ownership

Aclaris Therapeutics, Inc. Filed Acc 0001209191-20-034076

President and CEO gave up 20,976 shares (to pay taxes)

  • President and CEO acquired 73,014 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Walker Neal President and CEO 2020-06-01 Option exercise +73,014 1,107,907 D
Walker Neal President and CEO 2020-06-01 Shares withheld for taxes −20,976 $1.32 $27,688 1,086,931 D
Derivatives
Walker Neal President and CEO 2020-06-01 Option exercise · Restricted stock units −73,014 73,015 D
Loading xslF345X03/doc4.xml…